| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Amount of expense (income) related to adjustment to fair value of convertible debt | - | - | - | -95,551 |
| Amount of income related to employee retention credit under cares act | - | - | 66,444 | - |
| Total other income | 49,536 | 61,903 | 145,855 | 100,173 |
| Income (loss) from continuing operations before income taxes, noncontrolling interest | - | - | -1,719,381 | -1,644,502 |
| Net loss applicable to common stockholders | -2,530,947 | -2,701,976 | -1,719,381 | -1,644,502 |
| Earnings per share, basic | -0.58 | -0.82 | -0.78 | -1.31 |
| Earnings per share, diluted | -0.58 | -0.82 | -0.78 | -1.31 |
| Weighted average number of shares outstanding, basic | 4,329,649 | 3,278,677 | 2,203,929 | 1,258,985 |
| Weighted average number of shares outstanding, diluted | 4,329,649 | 3,278,677 | 2,203,929 | 1,258,985 |
SOLIGENIX, INC. (SNGX)
SOLIGENIX, INC. (SNGX)